“Medicine” Journal documents successful treatment of child at the “Damascus” Hospital
Under the title “Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis”, the “Medicine” Journal documented the treatment of A 13-year-old Syrian boy, who was suffering from Ulcerative colitis flare.
The boy was treated at Damascus hospital.
Golimumab has shown potential efficacy and safety in the treatment of ulcerative colitis in children which may indicate a significant future role for subcutaneous golimumab in pediatrics ulcerative colitis.
Below the link of the full article:
https://journals.lww.com/md-journal/Fulltext/2021/09240/Subcutaneous_golimumab_induced_and_maintained.45.aspx